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Summary
The p21-activated kinases (PAKs) participate in cy-
toskeletal control networks, downstream of Rho-fam-
ily GTPases. A structure of PAK1 in an autoregulated,
“off” state showed that a regulatory region, N-ter-
minal to the kinase domain, forces the latter into an
inactive conformation, prevents phosphorylation of
Thr423 in the activation loop, and promotes dimeriza-
tion. We have now determined structures at 1.8 Å res-
olution for the free PAK1 kinase domain, with a muta-
tion in the active site that blocks enzymatic activity,
and for the same domain with a “phosphomimetic”
mutation in the activation loop. The two very similar
structures show that even in the absence of a phos-
phorylated Thr423, the kinase has an essentially
active conformation. When Cdc42 binds the regula-
tory region and dissociates the dimer, PAK1 will be
in an “intermediate-active” state, with a capacity to
phosphorylate itself or other substrates even prior to
modification of its activation loop.
Introduction
Protein kinases are sensitive regulatory switches. They
respond in various, well defined ways to multiple in-
puts, which include phosphorylation of residues on the
kinase itself and association with activators or dere-
pressors. Good examples of such control elements are
the p21-activated kinases (PAKs), a family of serine-
threonine kinases represented in all eukaryotes (Bag-
rodia and Cerione, 1999; Bokoch, 2003; Sells and Cher-
noff, 1997). They participate in a wide range of cellular
control processes, including regulation of transcription
in response to pheromone signaling in yeast and modu-
lation of cytoskeletal dynamics in multicellular eukary-
otes. Rho-family p21 GTPases, specifically Cdc42 and
Rac in their GTP-bound forms, bind and stimulate
PAKs, both in vitro and in vivo (Knaus and Bokoch,
1998; Lim et al., 1996; Manser et al., 1994, 1997; Martin*Correspondence: harrison@crystal.harvard.edu
4 Present address: Department of Biological Chemistry, University
of Michigan Medical School, 5413 Medical Science I, 1301 Cather-
ine Road, Ann Arbor, Michigan 48109.et al., 1995). This common activation trigger gives the
family its name.
Like most protein kinases, PAKs have a phosphoryla-
table residue in their “activation loop”, a stretch of
about 30 residues in the large lobe of the kinase do-
main. This loop can adopt multiple conformations, and
modification promotes rearrangement to its “on” or
“active” state. In PAK1, the best studied of the mamma-
lian PAKs, the modifiable residue is Thr423. PAKs also
have regulatory segments that lie outside the kinase
domain. In PAK1, the key autoregulatory region (resi-
dues 67–150; Figure 1A) maintains an “off” state by
forcing the kinase domain (residues 249–545) into an
inactive conformation and by preventing phosphory-
lation of Thr 423 (Frost et al., 1998; Lei et al., 2000).
GTP-bound Cdc42 or Rac can interact with part of the
autoregulatory region, thereby prying it away from the
kinase, enabling phosphorylation of Thr423, and allow-
ing the kinase domain to adopt an active structure
(Hoffman and Cerione, 2000; Lei et al., 2000; Tu and
Wigler, 1999; Zenke et al., 1999; Zhao et al., 1998). The
autoregulatory region inhibits PAK1 even when sup-
plied in trans as an independent fragment.
The foregoing outline of activation is derived in part
from the structure of an autoinhibited PAK1 complex,
which we described in a previous article (Lei et al.,
2000). That complex (Figure 1B) included an N-terminal
regulatory fragment (residues 70–149, with elements
defined in Figure 1A) and the C-terminal kinase domain
(residues 249–545). In the structure, residues of the ki-
nase inhibitor (KI) segment block the cleft between the
two lobes of the kinase domain. Association of the in-
hibitory switch (IS) domain with the large lobe of the
kinase presents the KI segment appropriately. The lat-
ter pushes the activation loop of the kinase domain into
the active site, thereby preventing entry of ATP. NMR
structures of Cdc42 complexes with fragments of PAK
and WASP show that GTP-bound Cdc42 associates
with the p21 binding domain (PBD) segment, which
partly overlaps the IS domain (Abdul-Manan et al.,
1999; Morreale et al., 2000). This interaction causes the
IS domain to unfold, releasing the KI segment from the
cleft of the kinase. The kinase domain, no longer re-
strained, changes conformation. Thr423 also becomes
susceptible to phosphorylation, and its modification
stabilizes the active state. PAK1 can then autophos-
phorylate at several other sites to fix the active confor-
mation even more firmly by preventing refolding of the
IS domain even after Cdc42 dissociates.
Autoinhibited PAK1 is a dimer, in the crystal struc-
ture, in solution, and in cells (Lei et al., 2000; Parrini et
al., 2002). Part of the dimer contact is provided by a
segment N-terminal to the IS domain, but because the
crystals contained separate regulatory and kinase frag-
ments, the structure by itself left open the issue of cis-
or trans-autoinhibition. The effects of defined muta-
tions on intracellular homo- and heterodimerization of
coexpressed forms of PAK1 resolved the question and
showed that the autoinhibitory interaction is in trans—
in other words, that the IS domain and KI segment as-
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770Figure 1. Autoregulation of PAK1
(A) Organization of the PAK1 polypeptide
chain, with segments present in the crystal
structure of the inactive dimer (Lei et al.,
2000) shown in color (autoregulatory frag-
ment, yellow; kinase small lobe, light blue;
kinase large lobe, dark blue). The detailed
substructure of the autoregulatory region is
shown in the expanded lower part of the dia-
gram. The divisions of the upper bar corre-
spond to the p21 bound state; those in the
lower bar correspond to the autoinhibited
state. The autoregulatory fragment, N-ter-
minal to the kinase domain, adopts different
conformations in the inactive PAK1 dimer (in
which the dimerization segment [Di], the in-
hibitory switch domain [IS], and the kinase-
inhibiting segment [KI], have defined struc-
tural roles) and in complex with the activator,
Cdc42 (in which only the “PBD” segment has
a defined structure).
(B) Ribbon diagram of the inactive PAK1 di-
mer, illustrating how the autoregulatory frag-
ment enforces an inactive conformation of
the kinase domain and blocks (through the
position of the KI segment) the catalytic site.
All figures were prepared using MolScript
(Kraulis, 1991) and Raster3D (Merritt and
Murphy, 1994).sociated with an inhibited kinase domain belong to the l
apolypeptide chain of the other member of the dimer
(Parrini et al., 2002). a
cThe structure of PAK1 suggests that the phosphory-
lation state of Thr423 determines whether the kinase M
twill be susceptible to Cdc42-sensitive autoinhibition,
because the activation loop in its “on” conformation c
texcludes association of the autoregulatory region with
the kinase domain. Replacement of Thr423 by alanine w
cpartly inactivates PAK1 (Zenke et al., 1999), but the au-
toregulatory fragment (residues 67–150) supplied in Z
ttrans can still inhibit the residual Cdc42-stimulated ac-
tivity. Thus, the T423A mutation destabilizes the active p
astate, but does not significantly affect the inactive con-
formation. Moreover, the H83L PAK1(67–150) autoregu- o
rlatory fragment, which cannot bind Cdc42, inhibits
PAK1 T423A whether or not Cdc42 is present. By con- m
dtrast, the constitutively active PAK1 T423E mutant is
completely insensitive to inhibition by the wild-type au- a
ptoregulatory fragment, which has no effect on the ca-
pacity of the mutant kinase to phosphorylate other resi- h
dues or heterologous substrates (Zenke et al., 1999).
To visualize the “on” conformation of the kinase do- R
main of PAK1, we have determined two structures (Fig-
ure 2). One has the wild-type sequence, except for a O
Wchange from Lys to Arg at position 299 (equivalent, for
example, to Lys72 in protein kinase A [PKA]) (Knighton h
het al., 1991). This “kinase-dead” mutation inactivates
the enzyme, which would otherwise be toxic to the ex- i
wpressing cells. Evidence from other kinase structureseads us to believe that the mutation does not produce
ny large-scale conformational changes (Robinson et
l., 1996). Comparison of our structure with one re-
ently reported for the active kinase domain of TAO2, a
AP3K closely related to PAKs, supports this assump-
ion (Zhou et al., 2004). The second structure we report
ontains, in addition to the K299R substitution, a glu-
amic-acid residue at position 423 (T423E). When the
ild-type lysine is present at 299, T423E generates a
onstitutively active enzyme (Sells and Chernoff, 1997;
enke et al., 1999). That is, the glutamic acid substitu-
ion can, in this case, adequately mimic a phos-
hothreonine. The structures described here are actu-
lly quite similar (Figure 2). That is, even in the absence
f a phosphorylated threonine (or its glutamic acid sur-
ogate), the kinase adopts an essentially active confor-
ation. This result implies that once Cdc42 enters and
issociates the dimer, the enzyme is in an intermediate
ctive state, with significant capacity to modify other
arts of its own polypeptide chain or to phosphorylate
eterologous substrates.
esults and Discussion
verview
e expressed in Escherichia coli two variants of the
uman PAK1 kinase domain, residues 249–545. One
ad the K299R “kinase-dead” mutation; the other had,
n addition, the mutation T432E. The crystal structures
ere determined by molecular replacement using the
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771Figure 2. The Active PAK1 Kinase Domain
(A) Ribbon diagram showing conformation of the domain in the PAK1(K299R) and PAK1(K299R,T432E) structures (small lobe in light blue;
large lobe in dark blue; activation loop in red). Secondary-structure elements are labeled using previously established nomenclature for the
kinase domain (Knighton et al., 1991). In the autoinhibited PAK1 structure, four short β strands (β6 in the catalytic loop, β9 and β10 in the
activation loop, and β12 between helices EF and F), conserved in all the active kinase structures, are either disordered (β9 and β10) or folded
differently (β6 and β12). The activation loop (residues 405–430), partly disordered in the autoinhibited structure, is ordered in the active
conformation, with an average thermal parameter of 40 Å2 (compared with 36 Å2 for the entire kinase domain).
(B) Amino acid sequence of PAK1 kinase domain. Secondary structure assignments are shown above the sequence as cylinders (α helices)
and arrows (β strands), and colored as in (A). Residues in blue blocks are important for catalysis. The green and red blocks show the catalytic
loop and the activation loop, respectively.large lobe of the kinase domain of autoinhibited PAK1
as a search model. The X-ray diffraction data extended
to 1.8 Å resolution for both, and we refined the struc-
tures to overall Rfree values of 24.3 and 24.5% (Table 1).
Details of expression and structure determination are
reported in Experimental Procedures.
Both models contain residues 249–541, with 196
waters for K229R and 232 for the double mutant (Figure
2). The two structures are almost identical. The Cα
atoms of the small lobe and large lobe superpose well
on those of autoinhibited PAK1, with root-mean-
squared deviations of 1.09 and 0.94 Å, respectively. The
lobes are rotated toward one another by about 15° with
respect to their relative orientations in the autoinhibited
conformation. The activation loop is ordered in both
structures, with an average thermal parameter of 40 Å2,
essentially the same as the average of 36 Å2 for the
whole kinase domain.
Conformation of the Activation Loop
The activation loop in both structures, residues 327–
428, has the conformation typical of all active protein
kinases. In the double mutant (K229R, T432E), there is a
network of electrostatic side-chain interactions (Figure
3A). Glu423 forms salt bridges with Arg388 and Arg421,
thus helping to position the catalytic base, Asp389, as
well as to anchor the activation loop. Arg388, con-
served in both serine/threonine and tyrosine kinases
(Narayana et al., 1997), has additional hydrogen bonds
with the main-chain carbonyl of Phe410 and with the
phenolic oxygen of Tyr441. The latter interaction,thought to be characteristic of the active structures of
serine/threonine kinases dependent on phosphoryla-
tion of their activation loops (Zhou et al., 2004), is seen
here even in the K299R form, which lacks the “phos-
phomimetic” E432 (and, of course, lacks a phos-
phothreonine). Arg421 hydrogen bonds with the main-
chain carbonyl of Gln413. A contact between the side
chain of the latter residue and that of Asn314 (in helix
C) is the only contact between the activation loop and
the small lobe. Two short β strands (β9, residues 411–
414, and β10, residues 419–422), present in all active
kinase structures so far determined, guide the activa-
tion loop so that it passes toward the rear of the kinase
domain and then back forward and anchor the charge
network just described.
The conformation of the mutated PAK1 activation
loop closely resembles those of the phosphorylated
loops in PKA (Knighton et al., 1991) and Cdk2 (Russo
et al., 1996) and of the nonphosphorylatable loop in
phosphorylase kinase (PHK), which has a naturally oc-
curring glutamic acid at the position homologous to
PAK1 423 (Lowe et al., 1997). Indeed, PAK1 Glu423 (Fig-
ure 3A) appears to interact in the same way as PHK
Glu182 (Figure 3B), pThr197 in PKA (Figure 3C), and
pThr160 in Cdk2, and the equivalents of Arg388 and
Tyr441 are conserved in all these other kinases. There
are limits to the extent to which Glu423 adequately
mimics a pThr, however (Figure 3). In PKA, pT197 has
three hydrogen bonds, including one with Lys189 at the
N terminus of the activation loop (Figure 3C). In PAK1
(K299R,T432E), we instead observe a network that in-
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772Table 1. Statistics for Data Collection, Data Processing, Model Refinement, and Final Geometry of PAK1 Kinase Domain Structures
PAK1(K299R,T432E) PAK1(K299R)
Data collection and Processing Statistics
Resolution (Å) 50–1.8 50–1.8
Rsyma,b (%) 7.8 7.3
Total observations 307,639 123,637
Unique observations 30,537 28,485
Completeness (%) 98.6 92.4
<I/σ(I)> 9.5 11.3
Refinement Statistics
Total number of reflections (50–1.8 Å) 30,174 28,120
Working set: no. of reflections 28,681 26,751
R factor (%) 22.3 22.6
Test set: no. of reflections 1493 1369
Rfreec (%) 24.5 24.3
Total no. of residues (protein) 297 297
Total no. of water molecules 232 196
Geometry Statistics
Rmsdd (bond distance) (Å) 0.011 0.007
Rmsd (bond angle) (°) 1.63 1.31
Rmsd (B factor)
Main chain atoms (Å2) 1.08 0.79
Side chain atoms (Å2) 2.00 1.02
All atoms (Å2) 1.64 0.93
Average B factor
All protein atoms (Å2) 35.8 37.13
Main chain atoms (Å2) 34.4 39.65
Side chain atoms (Å2) 37.4 37.87
Water molecules (Å2) 46.2 43.6
χ1, χ2 imperfection (°)d 18.5 15.3
Ramachandran plote
Residues in most favored region (%) 89.8 88.6
Residues in additional allowed region (%) 9.1 10.1
Residues in generously allowed region (%) 1.1 1.3
Residues in disallowed region (%) 0 0
Rmsd, root-mean-square derivation from ideal geometry.
aRsym = Σ|I − <I>|/ΣI, where I is the observed intensity and <I> is the average intensity of multiple observations of symmetry-related reflections.
b R = Σ||Fo| − |Fc||/Σ|Fo|, where Fo and Fc are observed and calculated structure factor amplitudes, respectively.
c Rfree is calculated for a randomly chosen 5% of reflections; the R factor is calculated for the remaining 95% of reflections used for
structure refinement.
dχ1, χ2 imperfection value is the rms difference between observed χ1, χ2 values and the nearest preferred values as defined by a database
of well refined structures.
e Residue regions are defined by PROCHECK (Laskowski et al., 1993).cludes Glu423, Arg421, and Gln413. Because these last l
tresidues are on opposite sides of the activation loop,
the hydrogen bond between the side chain of Arg421 i
oand the main chain of Gln413 probably helps stabilize
the active conformation, even without Glu423 (as in our a
Csingly mutated K299R structure).
The activation loops in our two structures superpose f
mwell, and all side-chain interactions expected to stabi-
lize the active conformation are present in both, except m
for the two salt-bridge interactions of Glu423. The
structure of PAK1(K299R) presumably represents one l
tpossible conformation in the sequence of changes be-
tween release of the KI segment from the catalytic cleft t
t(after derepression by Cdc42) and phosphorylation of
Thr423. We refer to the unmodified but derepressed ki- B
Pnase as an “intermediate-active” state. The presence
of the Arg388/Tyr441 interaction is additional evidence d
sthat this form would have enzymatic activity were it not
for the K299R mutation. To accept a phosphate, the poop must breathe open again, and we presume that
his state is an equilibrium between the structure seen
n the crystal and an open, inactive conformation. The
bserved activity of the kinase will be an appropriate
verage over the various structures present in solution.
rystallization appears to have trapped the active con-
ormer. We suggest that the intermediate-active kinase
ay catalyze phosphorylation of Thr423 in other PAK1
olecules, leading to a cascade of activation events.
Structures of kinases with unmodified activation
oops fall into two classes. Cdk2 and IRK are illustra-
ions of enzymes that adopt inactive conformations in
heir resting states. The activation loop has an inhibi-
ory fold, blocking the sites for ATP and substrate (De
ondt et al., 1993; Hubbard et al., 1994). PAK1 and
KA, when freed of a negative regulator such as the IS
omain/KI segment (Figure 4A) or the R subunit, re-
pectively (Knighton et al., 1991; Lei et al., 2000), ap-
ear to relax into an active conformation.
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773Figure 3. The Activation Loop of PAK1 Compared with Those of
Phosphorylase Kinase and Protein Kinase A in Their Active States
(A) PAK1 (from the double-mutant structure), with side chains that
participate in an electrostatic network as described in the text.
(B) Phosphorylase kinase (PHK) (Lowe et al., 1997 [PDB accession
code 2PHK]), which has a glutamate in the activation loop at the
position corresponding to Thr423 of PAK1 (and mutated to Glu in
our double mutant).
(C) Protein kinase A (PKA) (Narayana et al., 1997 [PDB accession
code 1BKX]). The view in all three panels is as if looking from about
45° to the right in Figure 2A. Colors as in Figure 2.Figure 4. The ATP Binding Site of PAK1 Compared with That of PHK
(A) Inactive state of PAK1 (see Lei et al., 2000). The segment of the
inhibitory region that inserts into the outer part of the active site is
shown in yellow. Other colors are as in Figure 2.
(B) Active state of PAK1 (from the structures reported here).
(C) ATP bound form of PHK. The view in all three panels is the same
as the view in Figure 2A. Although there is no ATP or analog in the
PAK1(K299R,T432E) crystals, the overall architecture closely re-
sembles that of PHK complexed with ATP. Moreover, except for
mutation at position 299 from Lys to Arg, the residues important
for phosphoryltransfer occupy similar positions and adopt similar
orientations as they do in PHK.ATP Binding Site
The structure of the ATP binding pocket in the double
mutant structure very closely resembles those of the
ATP bound states of PHK (Lowe et al., 1997; Figures 4B
and 4C) and TAO2 (Zhou et al., 2004). The positions of
the tips of the two side chains in the invariant ion pair
are interchanged, however, with respect to the nucleo-
tide. Thus, unlike Lys48, Arg299 in kinase-dead PAK1
cannot contact the α and β phosphates, and the affinity
for ATP is probably low. Nearly precise superpositionof all other residues important for phosphoryl transfer
indicates that, except for Arg299, the PAK1(K299R,
T432E) structure represents an active conformation.
The P+1 Pocket
Apart from the activation loop, the only part of the large
lobe that differs in conformation from its counterpart in
autoinhibited PAK1 is the pocket between the helices
αEF and αG. This is the site for the substrate residue
that follows the targeted serine or threonine. In autoin-
hibited PAK1, it is occupied by hydrophobic side chains
from one face of the third helix in the inhibitory switch
domain. In the present structures, side-chain orienta-
tions and interactions, conserved in the active forms of
other kinases but disturbed in autoinhibited PAK1, are
restored. For example, the side chains of Tyr429,
Structure
774Trp430, and Met431 all have their canonical active-
state contacts. The likelihood of these rearrangements
has been suggested previously, based on the structure
of the active kinase domain of TAO2 (see Figure 5 in
the article by Zhou et al. [2004]).
“Extra” Helices and the Conformation
of the Small Lobe
A core domain (β1-αI) is conserved among essentially
all protein kinases, with important variability only in the
activation loop (between β9 and αF), in its phosphoryla-
table residue, and in the presence of an insert between
the two lobes in certain receptor tyrosine kinases
(Hanks and Hunter, 1995; Hanks and Quinn, 1991). Most
crystallographically determined kinase-domain struc-
tures reveal N- or C-terminal extensions, however, often
packed tightly against the core and contributing to its
compact fold. These extensions have no sequence re-
lationship to each other, and they adopt quite different
conformations. In the kinase domain of PAK1, for ex-
ample, there are three “extra” α helices, two (αA and
αB) at its N terminus and one (αJ) at its C terminus.
The N-terminal helices of the PAK1 kinase domain,
αA and αB, augment the fold of the small lobe. Helix A,
which contains a sequence motif conserved in the PAK
family from yeast to mammals (Figure 5), packs against
the surface formed by αC and β4/β5. It connects across
the top of the small lobe to β1, the first element of the
kinase core, through the single-turn αB. Several other
kinases have α helices roughly coincident with PAK1
αA. In extracellular signal-regulated kinase (ERK) 2, the F
C-terminal extension (residues 315–358) contains a he- (
lix known as αL16 (residues 338–353). When the small (
lobes of ERK2 and PAK1 are superposed on each other, h
sαL16 and αA coincide. Their N-to-C directions are the
wsame, and they both run parallel to αC. The hydropho-
lbic residues important for forming the binding interface
t
of these helices are conserved (Figure 5), despite wide- r
spread differences between the sequences of PAK and d
ERK2, which belong to different kinase families. P
(The structural relationship between the small lobes
iof PAK1 and ERK2 has not, of course, been evident
mfrom primary-structure alignment because the aug-
o
menting helices come from opposite termini of their ki- h
nase domains. Alignment of small-lobe sequences from a
various protein kinases (Hanks and Hunter, 1995)
shows that the residues in αC, β4, and β5 that create
the hydrophobic groove for αA in PAK1 and αL16 in C
sERK2 are quite broadly conserved. Thus, we anticipate
that there will be a hydrophobic groove on the surface e
mof the small lobe of most protein kinases and that ele-
ments from elsewhere in the kinase polypeptide chain, m
ror from other regulatory proteins, will interact there
(Griffith et al., 2004; Huse et al., 1999; Wybenga-Groot c
et al., 2001). The same small-lobe surface is also the
interaction site for cyclins and cyclin-like proteins in R
Wtheir complexes with Cdks (Brotherton et al., 1998;
Russo et al., 1996), although no single helix from the t
icyclin domain appears to insert quite like the ones we
have just described. r
dAt the C terminus of the kinase domain, αJ packs
against the interdomain hinge (Lei et al., 2000). In l
PSte20, the yeast homolog of PAK1, the correspondingigure 5. The “Extra” Helices in the Small Lobes of Various Kinases
A) Comparison of the PAK1 small lobe (yellow) with that of ERK2
green) (Zhang et al., 1994 [PDB accession code 1ERK]). The extra
elices superimpose closely, although αA in PAK1 comes from a
egment of polypeptide chain just N-terminal to the small lobe,
hereas αL16 in ERK2 comes from a segment just C-terminal to the
arge lobe. The orientations of αA and αL16 are the same, so that
hey pair with the C helix in antiparallel fashion. Side chains of the
esidues shown in the figure are largely conserved. Labels for resi-
ues in ERK2 are in italics, to differentiate them from residues in
AK1.
B) Sequences of “extra” helices in members of the PAK family,
ncluding Ste20 (S. cerevisiae), and various MAP kinases. The align-
ent with the MAP kinase family is based on the crystal structure
f ERK2 (Zhang et al., 1994). The gray boxes show the conserved
ydrophobic residues important for interactions between αA, αC,
nd the β sheet; the red box shows polar residues in αA.-terminal sequence is a target for regulation by Gβγ in
ignaling from the yeast pheromone receptor (Leberer
t al., 2000; Leeuw et al., 1998). Pheromone signaling
ight influence Ste20 activity by influencing the relative
obility of the two lobes, just as assembly of the Src
egulatory apparatus clamps the kinase into an inactive
onformation (Xu et al., 1999).
otation of the Small Lobe
hen PAK1 is activated, release of the KI segment from
he catalytic cleft and phosphorylation of Thr423 (mim-
cked by glutamic acid in PAK1[K299R,T432E]) induce a
eorientation of the small and large lobes of the kinase
omain with respect to each other. By superposing the
arge lobes in the structures of autoinhibited PAK1 and
AK1(K299R,T432E), we find that the small lobe rotates
Active Conformation of PAK1 Kinase Domain
775about 15° toward the large lobe, about an axis passing
through Asn326 in the loop between αC and β4, and
Gly350 in the connection between the two lobes (Figure
6). Helix C moves about 5 Å toward the active site, cre-
ating contacts that stabilize the catalytic center (Fig-
ure 3B).
The shift of the small lobe in PAK1 is a rigid-body
motion; the small-lobe coordinates from the two struc-
tures superpose well on each other (Figure 7A). The
same is true of ERK2, for which structures of active and
inactive states are known (Figure 7B) (Canagarajah et
al., 1997; Zhang et al., 1994). We believe that the extra
helices, αA in PAK1 and αL16 in ERK2, lock αC into a
fixed position with respect to the rest of the small lobe.
By contrast, when kinases, such as Cdks, Src family
members, and insulin-receptor kinase (IRK), which do
not have an extra small-lobe helix, undergo activation,
αC can shift by as much as 10 Å relative to other small-
lobe secondary-structure elements (Figures 7C and 7D)
(De Bondt et al., 1993; Hubbard, 1997; Hubbard et al.,
1994; Russo et al., 1996; Xu et al., 1999; Yamaguchi and
Hendrickson, 1996). The shift in αC in these proteins is
a combination of two rotations, about axes perpendicu-
lar to each other (Figure 7E). In the overall PAK1 activa-
tion transition, which includes both an overall rotation
of the small lobe as well as the internal shift in αC, the
αC-β4 loop and the C terminus of αC are almost sta-
tionary, and the αC-β4 loop anchors the small lobe by
inserting into a pocket in the large lobe.
The correlation between the presence of αA, which
locks αC in place, and the intrinsic activity of PAK1,
which catalyzes phosphotransfer even when the activa-
tion loop is not phosphorylated, is striking. But not all
kinases that are intrinsically active in the absence of
phosphorylation have such a lock, nor is Erk2, which
does have one, active without being phosphorylated.
That is, αC can, in some kinases, adopt a catalytically
competent position even without reinforcement, and
when present, such reinforcement only fixes the struc-
ture of the small lobe and does not determine the pref-
erences of the activation loop. The position of αC and
the conformation of the activation loop are independent
switching elements that contribute to the overall logical
response of the kinase.Figure 6. Transition from Inactive to Active
State
(A) Superposition of the large lobes of au-
toinhibited PAK1 (blue) (Lei et al., 2000) and
PAK1(K299R,T432E) (yellow). The autoregu-
latory fragment is in green. The small lobe
moves as a rigid body with two pivot points
(N326 and G350). The rotation axis (red)
passes through residue N326. The black ar-
row specifies the rotation required to align
the small lobe of the autoinhibited kinase do-
main with that of the double-mutant kinase
domain. The C terminus of the KI segment in
the autoinhibited structure partially overlaps
the N terminus of the activation loop of
PAK1(K299R,T432E) and prevents it from
adopting an active conformation.
(B) As in (A), but viewed from the left. The
rotation axis (red circle and cross) is perpen-
dicular to the paper and passes through resi-
due N326.The Logic of PAK1
What sort of regulatory program does PAK1 execute?
We can distinguish four distinct states of the protein:
(1) the autoinhibited dimer; (2) the monomer released
from inhibition (e.g., by binding Cdc42 or Rac1) but
otherwise unmodified; (3) the monomer activated by
phosphorylation at Thr423; and (4) the monomer further
modified by phosphorylation at several serine residues,
including two (144 and 149) that could prevent reestab-
lishing the autoinhibited structure (Manser et al., 1997).
State 1 corresponds to the structure previously de-
scribed (Lei et al., 2000). State 2 has an intermediate
activity because it is actually a mixture of two sub-
states—one (2#) with the activation loop disordered
(e.g., as in state 1) or folded into an inactive conforma-
tion; the other (2##) with the activation loop folded into
an active conformation (as seen here in the structure
of KD). The equilibrium under crystallization conditions
evidently favors the latter substate, given the structure
found in the crystals, unless that equilibrium is influ-
enced by the K299R substitution. Taking the autoinhib-
ited dimer as the initial state of the protein, transition
to state 2# will occur if Cdc42 (or Rac1) is nearby and
if that molecule is “on” (GTP bound conformation). As
long as Cdc42 remains bound, there will then be a
(probably rapid) shift back and forth between 2# and
2##, but only 2# can make the transition to state 3 (i.e.,
serve as a substrate for a kinase that modifies Thr423).
One plausible candidate for such a kinase is the freshly
dissociated dimer partner, but results of experiments
using in vitro autophosphorylation do not conform to
this expectation (Parrini et al., 2002). In principle, Cdc42
dissociation could still allow return to the initial, in-
active state, with pThr423 exposed (the entire second
half of the activation loop appears to be disordered in
the autoinhibited structure [Lei et al., 2000]), but further
phosphorylation at Ser144 and Ser149 (inter alia), prob-
ably carried out in cis (Parrini et al., 2002), would pre-
vent correct insertion of the KI loop, even if the dimer
were to reform. A corresponding finite-state automaton
would have three one-bit inputs (“yes” or “no” for
bound Cdc42, pThr423, and pSer144+149), and could
probably be assigned a single-bit output (inactive or
active).
Structure
776Figure 7. Correlation between the Absence or Presence of an Extra Helix in the Small Lobe and the Displacement of the C Helix during Acti-
vation
Active (yellow) and inactive (blue) conformations of four kinases have been superposed using the small-lobe β sheet.
(A) PAK1.
(B) ERK2 (Canagarajah et al., 1997 [PDB accession code 2ERK]; Zhang et al., 1994 [PDB accession code 1ERK]).
(C) IRK (Hubbard, 1997 [PDB accession code 1IR3]; Hubbard et al., 1994 [PDB accession code 1IRK]).
(D) Cdk2 (De Bondt et al., 1993 [PDB accession code 1HCK]; Russo et al., 1996 [PDB accession code 1JST]).
(E) In IRK, Cdk2, and a number of other kinases that lack an extra small-lobe helix, αC swings into the active site upon activation of the
enzyme (e.g., by phosphorylation of the activation loop, as in IRK, or by binding of a cyclin, as in Cdk2). The motion of αC can be decomposed
into two rotations (θ1 and θ2), which move the helix away from the active site and break the interaction (orange circle) between the conserved
catalytic-site lysine in β3 and the glutamic acid in αC.
(F) In PAK1 and ERK2, hydrophobic contacts (blue lines) with the extra helix prevent αC from swinging outward, even in the inactive form of
the kinase.Conclusions t
fThe two very similar structures described in this article
show that when it is relieved of specific autoinhibition, yhe PAK1 kinase domain relaxes into an equilibrium that
avors an active conformation, even without phosphor-
lation of the activation loop. Modification of Ser144
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777and Ser149 can then eliminate the possibility of restor-
ing the inactive conformation, whatever the phosphory-
lation state of Thr423. Thus, the enzyme behaves as
a relatively simple, effectively irreversible switch. Were
phosphorylation of Thr423 essential for even partial ac-
tivity, the regulatory properties of PAK would instead
resemble those of a timer that balances the rate of
Cdc42 unbinding against the rate of Thr423 modifica-
tion (e.g., by another kinase recruited to the linker re-
gion between the IS and kinase domains of PAK).
Experimental Procedures
Cloning, Expression, and Purification
The kinase domain (residues 249–545) of human PAK1 was cloned
into the GST-fusion vector pGEX2N (Pharmacia), with a thrombin
cleavage site C-terminal to the GST moiety and with a gene
for ampicillin resistance. Both constructs, PAK1(K299R) and
PAK1(K299R,T432E), contained the inactivating mutation K299R
because the wild-type form is toxic to bacterial cells. The T423E
mutation was performed using the QuikChange Site-Directed Mu-
tagenesis Kit from Stratagene. The proteins were expressed and
purified as described before (Lei et al., 2000).
Crystallization, Data Collection, and Processing
Crystals of the single and double mutant were grown by hanging-
drop vapor diffusion by equilibrating against 23% PEG4000, 1.5 M
NaCl, 10 mM DTT, 100 mM PIPES, pH 6.5 (well solution), and 28%
PEG4000, 1.0 M NaCl, 10 mM DTT, 100 mM PIPES, pH 6.5, respec-
tively. Each drop contained 2 µl protein solution in buffer C plus 2
µl well solution. The crystals grew to 100–200 m in about 10 days
at 4°C. For data collection at low temperature, crystals were trans-
ferred stepwise into a stabilizing solution containing 25% glycerol,
25% PEG4000, 1.5 M NaCl, 10 mM DTT, 100 mM PIPES, pH 6.5,
for PAK1(K299R,T432E), or 25% glycerol, 30% PEG4000, 1.0 M
NaCl, 10 mM DTT, 100 mM PIPES, pH 6.5, for PAK1(K299R). The
crystals were flash-frozen by immersion in liquid nitrogen. Diffrac-
tion data were collected at APS Beamline BM 14-C using an ADSC
Quantum-4 detector. Data were integrated and scaled using the
HKL programs (DENZO and SCALEPAK) (Otwinowski and Minor,
1997). The crystals are in space group C2221, a = 51.96 Å, b =
103.30 Å, c = 122.88 Å for crystals of the double mutant and a =
51.76 Å, b = 103.05 Å, c = 122.64 Å for those of PAK1(K299R). The
final data-processing statistics are presented in Table 1.
Structure Determination
The initial phases for PAK1(K299R, T432E) were obtained by molec-
ular replacement using AmoRe (Navaza, 1994). The large lobe of
the kinase domain from the 2.3 Å resolution structure of autoinhib-
ited PAK1 (Lei et al., 2000) was used as the search model; because
the activation loop usually has different conformations in inactive
and active states, residues 403–430 were omitted. The calculation
used data between 15 and 3.5 Å resolution. The best rotation-
translation solution had a correlation of 28% and an R factor of
51%. The overall position of the initial large-lobe model obtained
from molecular replacement was first refined by rigid-body refine-
ment with the program CNS (Brunger et al., 1998), using data be-
tween 50 and 1.8 Å. The Rfree was reduced from 49% to 47%, and
the R factor for the reflections in the working set decreased from
48% to 46%. Further refinement was made using the maximum
likelihood approach as implemented in CNS. Model building was
performed with the program “O” using the weighted electron den-
sity map (Jones et al., 1991). The density for the large lobe was
very clear, and after several refinement rounds, when the R factor
dropped to 41% (Rfree = 48%), the difference density maps showed
the residues of the small lobe and those of the activation loop.
During a further few rounds of refinement, each followed by re-
building, a model was built that contained most of the small lobe
and activation loop. The validity of each step of rebuilding the small
lobe was monitored by the Rfree. Water molecules were added
gradually using CNS. A total of 232 water molecules were included
in the final coordinates for the double mutant. At this stage, boththe 2Fo − Fc and the Fo − Fc electron density maps showed clear,
positive density for the side-chain of glutamic acid 423. After the
final refinement cycle, the Rfree was 24.5% and the R factor was
22.3% for data between 50 and 1.8 Å (Table 1). Because the space
groups and cell dimensions of the two variants are the same, an
initial model of the single mutant was obtained by applying rigid-
body refinement (CNS) to the double-mutant coordinates without
the activation loop (residues 405–430) using the single mutant data-
set. Further refinement and model rebuilding were performed using
the programs CNS and O, respectively. The electron density of the
activation loop could be seen after the first-round refinement. The
final structure includes residues 249–545 and 196 water molecules.
The Rfree is 24.3% and the R factor is 22.6% for data between 50
and 1.8 Å (Table 1). The quality of both models of was assessed
with the structure validation program PROCHECK (Table 1)
(Laskowski et al., 1993). Some minor corrections were made based
on the results of PROCHECK.
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